A citation-based method for searching scientific literature

Megan E Miller, Alexandra Kyrillos, Katharine Yao, Olga Kantor, Jennifer Tseng, David J Winchester, Lawrence N Shulman. Ann Surg Oncol 2016
Times Cited: 14







List of co-cited articles
61 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Sentinel lymph node biopsy for patients with early-stage breast cancer: American Society of Clinical Oncology clinical practice guideline update.
Gary H Lyman, Sarah Temin, Stephen B Edge, Lisa A Newman, Roderick R Turner, Donald L Weaver, Al B Benson, Linda D Bosserman, Harold J Burstein, Hiram Cody,[...]. J Clin Oncol 2014
452
64

Ductal carcinoma in situ at core-needle biopsy: meta-analysis of underestimation and predictors of invasive breast cancer.
Meagan E Brennan, Robin M Turner, Stefano Ciatto, M Luke Marinovich, James R French, Petra Macaskill, Nehmat Houssami. Radiology 2011
204
50

Sentinel lymph node biopsy can be omitted in DCIS patients treated with breast conserving therapy.
L M van Roozendaal, B Goorts, M Klinkert, K B M I Keymeulen, B De Vries, L J A Strobbe, C A P Wauters, Y E van Riet, E Degreef, E J T Rutgers,[...]. Breast Cancer Res Treat 2016
34
42

Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
Mathias Worni, Igor Akushevich, Rachel Greenup, Deba Sarma, Marc D Ryser, Evan R Myers, E Shelley Hwang. J Natl Cancer Inst 2015
101
35

American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer.
Gary H Lyman, Armando E Giuliano, Mark R Somerfield, Al B Benson, Diane C Bodurka, Harold J Burstein, Alistair J Cochran, Hiram S Cody, Stephen B Edge, Sharon Galper,[...]. J Clin Oncol 2005
35

DCIS and axillary nodal evaluation: compliance with national guidelines.
Katrina B Mitchell, Heather Lin, Yu Shen, Alfred Colfry, Henry Kuerer, Simona F Shaitelman, Gildy V Babiera, Isabelle Bedrosian. BMC Surg 2017
22
35

The Influence of Hospital and Surgeon Factors on the Prevalence of Axillary Lymph Node Evaluation in Ductal Carcinoma In Situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Ling Chen, Dawn L Hershman. JAMA Oncol 2015
15
28

Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer.
Anne Fleissig, Lesley J Fallowfield, Carolyn I Langridge, Leigh Johnson, Robert G Newcombe, J Michael Dixon, Mark Kissin, Robert E Mansel. Breast Cancer Res Treat 2006
317
28



Predictors of invasive breast cancer in patients with an initial diagnosis of ductal carcinoma in situ: a guide to selective use of sentinel lymph node biopsy in management of ductal carcinoma in situ.
Tina W F Yen, Kelly K Hunt, Merrick I Ross, Nadeem Q Mirza, Gildy V Babiera, Funda Meric-Bernstam, S Eva Singletary, W Fraser Symmans, Sharon H Giordano, Barry W Feig,[...]. J Am Coll Surg 2005
197
28

Sentinel lymph node biopsy is not warranted following a core needle biopsy diagnosis of ductal carcinoma in situ (DCIS) of the breast.
Susan Prendeville, Ciara Ryan, Linda Feeley, Fionnuala O'Connell, Tara Jane Browne, Martin J O'Sullivan, Michael W Bennett. Breast 2015
24
28

Shoulder and arm morbidity in sentinel node-negative breast cancer patients: a systematic review.
Hanne Verbelen, Nick Gebruers, Fau-Mei Eeckhout, Kim Verlinden, Wiebren Tjalma. Breast Cancer Res Treat 2014
72
28

Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes.
Beth A Virnig, Todd M Tuttle, Tatyana Shamliyan, Robert L Kane. J Natl Cancer Inst 2010
356
21

Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ.
Tomohiro Miyake, Kenzo Shimazu, Hiroshi Ohashi, Tetsuya Taguchi, Satsuki Ueda, Takahiro Nakayama, Seung Jin Kim, Katsuyuki Aozasa, Yasuhiro Tamaki, Shinzaburo Noguchi. Am J Surg 2011
31
21

Is Sentinel Lymph Node Dissection Warranted for Patients with a Diagnosis of Ductal Carcinoma In Situ?
Ashleigh M Francis, Christine E Haugen, Lynn M Grimes, Jaime R Crow, Min Yi, Elizabeth A Mittendorf, Isabelle Bedrosian, Abigail S Caudle, Gildy V Babiera, Savitri Krishnamurthy,[...]. Ann Surg Oncol 2015
39
21

Sentinel Node Procedure Obsolete in Lumpectomy for Ductal Carcinoma In Situ.
Cathelijne Heymans, James van Bastelaar, Ruben G J Visschers, Yvonne L J Vissers. Clin Breast Cancer 2017
10
30


Is sentinel lymph node biopsy indicated in patients with a diagnosis of ductal carcinoma in situ? A systematic literature review and meta-analysis.
Hiba El Hage Chehade, Hannah Headon, Umar Wazir, Houssam Abtar, Abdul Kasem, Kefah Mokbel. Am J Surg 2017
20
21

Risk factors for invasive breast cancer when core needle biopsy shows ductal carcinoma in situ.
Emil D Kurniawan, Allison Rose, Arlene Mou, Malcolm Buchanan, John P Collins, Matthew H Wong, Julie A Miller, G Bruce Mann. Arch Surg 2010
52
21

Sentinel node biopsy is not a standard procedure in ductal carcinoma in situ of the breast: the experience of the European institute of oncology on 854 patients in 10 years.
Mattia Intra, Nicole Rotmensz, Paolo Veronesi, Marco Colleoni, Simona Iodice, Giovanni Paganelli, Giuseppe Viale, Umberto Veronesi. Ann Surg 2008
79
21


Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
Anthony Lucci, Linda Mackie McCall, Peter D Beitsch, Patrick W Whitworth, Douglas S Reintgen, Peter W Blumencranz, A Marilyn Leitch, Sukumal Saha, Kelly K Hunt, Armando E Giuliano. J Clin Oncol 2007
499
21

Axillary node staging for microinvasive breast cancer: is it justified?
John M Lyons, Michelle Stempel, Kimberly J Van Zee, Hiram S Cody. Ann Surg Oncol 2012
24
21

Associations Between Sentinel Lymph Node Biopsy and Complications for Patients with Ductal Carcinoma In Situ.
Brigid K Killelea, Jessica B Long, Weixiong Dang, Sarah S Mougalian, Suzanne B Evans, Cary P Gross, Shi-Yi Wang. Ann Surg Oncol 2018
16
21

Sentinel Lymph Node Biopsy for Patients With Early-Stage Breast Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
Gary H Lyman, Mark R Somerfield, Linda D Bosserman, Cheryl L Perkins, Donald L Weaver, Armando E Giuliano. J Clin Oncol 2017
167
21

Factors associated with lymph node assessment in ductal carcinoma in situ: analysis of 1988-2002 seer data.
Matthew R Porembka, Rebecca L Abraham, Julianne A Sefko, Anjali D Deshpande, Donna B Jeffe, Julie A Margenthaler. Ann Surg Oncol 2008
16
14


Breast Cancer Mortality After a Diagnosis of Ductal Carcinoma In Situ.
Steven A Narod, Javaid Iqbal, Vasily Giannakeas, Victoria Sopik, Ping Sun. JAMA Oncol 2015
299
14

Importance of lymphatic mapping in ductal carcinoma in situ (DCIS): why map DCIS?
C E Cox, K Nguyen, R J Gray, C Salud, N N Ku, E Dupont, L Hutson, E Peltz, G Whitehead, D Reintgen,[...]. Am Surg 2001
165
14

Axillary sentinel lymph node biopsy in patients with pure ductal carcinoma in situ of the breast.
Mattia Intra, Paolo Veronesi, Giovanni Mazzarol, Viviana Galimberti, Alberto Luini, Virgilio Sacchini, Giuseppe Trifirò, Oreste Gentilini, Giancarlo Pruneri, Paola Naninato,[...]. Arch Surg 2003
119
14

Predictors of treatment with mastectomy, use of sentinel lymph node biopsy and upstaging to invasive cancer in patients diagnosed with breast ductal carcinoma in situ (DCIS) on core biopsy.
Laura Chin-Lenn, Lloyd A Mack, Walley Temple, William Cherniak, Robert R Quinn, Pietro Ravani, Adriane M Lewin, May Lynn Quan. Ann Surg Oncol 2014
23
14

Ductal carcinoma in situ diagnosed at US-guided 14-gauge core-needle biopsy for breast mass: preoperative predictors of invasive breast cancer.
Ah Young Park, Hye Mi Gweon, Eun Ju Son, Miri Yoo, Jeong-Ah Kim, Ji Hyun Youk. Eur J Radiol 2014
29
14

Sentinel lymph node biopsy in clinically detected ductal carcinoma in situ.
Ahmed Yahia Al-Ameer, Sahar Al Nefaie, Badria Al Johani, Ihab Anwar, Taher Al Tweigeri, Asma Tulbah, Mohmmed Alshabanah, Osama Al Malik. World J Clin Oncol 2016
8
25

Incidence and prediction of invasive disease and nodal metastasis in preoperatively diagnosed ductal carcinoma in situ.
Tomo Osako, Takuji Iwase, Masaru Ushijima, Rie Horii, Yasuyoshi Fukami, Kiyomi Kimura, Masaaki Matsuura, Futoshi Akiyama. Cancer Sci 2014
24
14

Core biopsy diagnosis of ductal carcinoma in situ: an indication for sentinel lymph node biopsy.
Elizabeth A Mittendorf, Cletus A Arciero, Veronica Gutchell, Jeff Hooke, Craig D Shriver. Curr Surg 2005
64
14

Addressing overtreatment of screen detected DCIS; the LORIS trial.
Adele Francis, Jeremy Thomas, Lesley Fallowfield, Matthew Wallis, John M S Bartlett, Cassandra Brookes, Tracy Roberts, Sarah Pirrie, Claire Gaunt, Jennie Young,[...]. Eur J Cancer 2015
179
14



The role of sentinel node biopsy in ductal carcinoma in situ of the breast.
K Polom, D Murawa, J Wasiewicz, W Nowakowski, P Murawa. Eur J Surg Oncol 2009
18
14

Sentinel lymph node biopsy in patients with a needle core biopsy diagnosis of ductal carcinoma in situ: is it justified?
B Doyle, M Al-Mudhaffer, M M Kennedy, A O'Doherty, F Flanagan, E W McDermott, M J Kerin, A D Hill, C M Quinn. J Clin Pathol 2009
28
14

International variation in management of screen-detected ductal carcinoma in situ of the breast.
Antonio Ponti, Elsebeth Lynge, Ted James, Ondřej Májek, My von Euler-Chelpin, Ahti Anttila, Patricia Fitzpatrick, Maria Piera Mano, Masaaki Kawai, Astrid Scharpantgen,[...]. Eur J Cancer 2014
26
14

A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer.
Umberto Veronesi, Giovanni Paganelli, Giuseppe Viale, Alberto Luini, Stefano Zurrida, Viviana Galimberti, Mattia Intra, Paolo Veronesi, Chris Robertson, Patrick Maisonneuve,[...]. N Engl J Med 2003
14


The Nordic SentiMag trial: a comparison of super paramagnetic iron oxide (SPIO) nanoparticles versus Tc(99) and patent blue in the detection of sentinel node (SN) in patients with breast cancer and a meta-analysis of earlier studies.
Andreas Karakatsanis, Peer Michael Christiansen, Lone Fischer, Christina Hedin, Lida Pistioli, Malin Sund, Nils Ryegaard Rasmussen, Hjørdis Jørnsgård, Daniel Tegnelius, Staffan Eriksson,[...]. Breast Cancer Res Treat 2016
51
14

Axillary evaluation and lymphedema in women with ductal carcinoma in situ.
Ellie J Coromilas, Jason D Wright, Yongmei Huang, Sheldon Feldman, Alfred I Neugut, Grace Clarke Hillyer, Ling Chen, Dawn L Hershman. Breast Cancer Res Treat 2016
11
18


Trends and clinicopathological predictors of axillary evaluation in ductal carcinoma in situ patients treated with breast-conserving therapy.
Nai-Si Huang, Jing Si, Ben-Long Yang, Chen-Lian Quan, Jia-Jian Chen, Jiong Wu. Cancer Med 2018
3
66

Ductal carcinoma in situ with microinvasion: prognostic implications, long-term outcomes, and role of axillary evaluation.
Rahul R Parikh, Bruce G Haffty, Donald Lannin, Meena S Moran. Int J Radiat Oncol Biol Phys 2012
49
14

Factors predicting microinvasion in Ductal Carcinoma in situ.
Sibel Ozkan-Gurdal, Neslihan Cabioglu, Beyza Ozcinar, Mahmut Muslumanoglu, Vahit Ozmen, Mustafa Kecer, Ekrem Yavuz, Abdullah Igci. Asian Pac J Cancer Prev 2014
31
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.